Current Report Filing (8-k)
January 26 2017 - 5:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
___________________
FORM 8-K
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (date of earliest event reported):
January 27, 2017
OWC
PHARMACEUTICAL RESEARCH CORP.
(Exact Name of
Registrant as Specified in its Charter)
Commission File No.: 0-54856
Delaware
|
98-0573566
|
(State of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
|
30 Shacham
Street, P.O.B.
8324, Petach Tikva, Israel
|
4918103
|
(Address of Principal Executive Offices)
|
(ZIP Code)
|
Registrant's
Telephone Number, including area code: 972 (0) 3-758-2657
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On January 27, 2017, OWC Pharmaceutical
Research Corp. issued a press release announcing that Ms. Miri Sani has accepted
her nomination to the Company's Advisory Board. The press release is attached to
this Form 8-K as Exhibit 99.1.
Exhibit
No.
|
Description
|
99.1
|
Press Release issued by OWC
Pharmaceutical Research Corp. dated January 27, 2017.
|
|
|
|
OWC Pharmaceutical
Research Corp.
|
|
|
|
|
|
By:
|
/s/ Mordechai
Bignitz
|
|
Name:
|
Mordechai Bignitz
|
|
Title:
|
Chief Executive
Officer
|
Date: January 27, 2017
OWC Pharmaceuticals Rese... (CE) (USOTC:OWCP)
Historical Stock Chart
From Mar 2024 to Apr 2024
OWC Pharmaceuticals Rese... (CE) (USOTC:OWCP)
Historical Stock Chart
From Apr 2023 to Apr 2024